The present invention is directed to a solid form comprising an active ingredient and croscarmellose wherein: (i) the croscarmellose has a median particle size of = 56 microns (ii) the croscarmellose is present in an amount of = 4% by weight based on the total weight of the solid form and (iii) the solid form is a tablet capsule caplet lozenge or granule. The present invention is also directed to a method of decreasing the disintegration time (for example in water) of a solid form that comprises croscarmellose in an amount = 4% by weight based on the total weight of the solid form.
